logo_new_en

International current projects

Name

Acronym

Project manager

Programme

Duration

EATRIS-CONNECT     EATRIS-CONNECT     Prof. Irena Mlinarič-Raščan, M. Pharm., Ph. D.     HORIZON-RIA    01. 05. 2024 - 30. 04. 2027 
Degradation of CDK1 and HDACs as a strategy to treat T-cell malignancies    CELSA/23/038    Assoc. Prof. Izidor Sosič, PhD   CELSA    1. 10. 2023 - 30. 9. 2025 
Exploiting structural insights in IP3 receptor function to develop novel, allosteric inhibitors of IP3 receptor channels (SINFONIC)
  CELSA/23/031

  Prof. Tihomir Tomašič, PhD
Prof. Lucija Peterlin Mašič, PhD
 
  CELSA    1. 10. 2023 - 30. 9. 2025 
A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer GlyCanDrug Prof. Marko Anderluh, Ph. D. Horizon Europe 1. 12. 2023 – 30. 11. 2027
Protein degraders for targeting galectin-8 PROTAG-8 Prof. Marko Anderluh, Ph. D. Horizon Europe 1. 9. 2024 – 31. 8. 2026
The role of snoRNAs in the etiology of inflammatory bowel disease Assoc. Prof. Tomaž Bratkovič, Ph. D. CELSA 1.10.2022 - 30.9.2024
Razvoj raziskovalne infrastrukture za mednarodno konkurenčnost slovenskega RRI prostora Prof. Irena Mlinarič-Raščan, Ph. D. EATRIS ERIC 2021 - 2030
Digital Osce for Medical specialities - INnOvatlon for Students DOMINOS Prof. Mitja Kos, Ph. D. ERASMUS+ 1.1.2022 - 31.12.2024
EATRIS-Plus – flagship in personalized medicine EATRIS Plus Prof. Irena Mlinarič-Raščan, Ph. D. H2020 1.1.2020 - 31.12.2023
REMEDI4ALL REMEDI4ALL Prof. Irena Mlinarič-Raščan, Ph. D.
Prof. Rok Dreu, Ph. D.
Horizon Europe 1. 9. 2021 - 31. 8. 2027
European Partnership for the Assessment of Risks from Chemicals (PARC) PARC Prof. Marija Sollner Dolenc, Ph. D. Horizon Europe 1. 5. 2022 - 30. 4. 2029
Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable BREAKthrough Prof. Stanislav Gobec, Ph. D. Horizon Europe 1. 1. 2023 – 31. 12. 2026
Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology    SIMPATHIC   Prof. Rok Dreu, M. Pharm., Ph. D.    Horizon Europe    1. 7. 2023 – 30. 6. 2028